Oncoinvent ASA Stock Forecast

Stock Price Forecast

According to 2 analysts polled by S&P Global, Oncoinvent ASA stock has a consensus rating of "Strong Buy" and an average price target of kr 59.50. The average 1-year stock price forecast is 23.96% higher than the current stock price, while the lowest is kr 49.00 (+2.08%) and the highest is kr 70.00 (+45.83%).

Price Target: kr 59.50 (+23.96%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	kr 49.00	kr 59.50	kr 59.50	kr 70.00
Change	+2.08%	+23.96%	+23.96%	+45.83%

Analyst Ratings

The average analyst rating for Oncoinvent ASA stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Feb '26	Apr '26
Strong Buy	1	2
Buy	0	0
Hold	0	0
Sell	0	0
Strong Sell	0	0
Total	1	2

Financial Forecast

Revenue This Year

27.50M

from 28.07M

-2.03%

from 28.07M

Revenue Next Year

25.50M

from 27.50M

-7.27%

from 27.50M

EPS This Year

-20.68

from -

EPS Next Year

-26.14

from -20.68

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	11.08M	6.28M	5.79M	8.10M	28.07M	27.50M
Revenue Growth	6.80%	-43.31%	-7.85%	39.95%	246.40%	-2.03%
Operating Income	-80.83M	-110.61M	-147.43M	-141.02M	-158.33M	-171.50M
Net Income	-80.29M	-106.28M	-143.62M	-140.20M	-155.07M	-165.50M
EPS	-	-	-	-	-	-20.68
Free Cash Flow	-	-52.26M	-110.11M	-34.76M	-85.19M	-169.50M
No. Analysts	-	-	-	-	-	2

EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is NOK.

Revenue Forecast

Revenue	2026	2027	2028
High	30.0M
Avg	27.5M
Low	25.0M

Revenue Growth

Revenue Growth	2026	2027	2028
High	6.9%
Avg	-2.0%
Low	-10.9%

EPS Forecast

EPS	2026	2027	2028
High	-
Avg	-20.68
Low	-

EPS Growth

EPS Growth	2027	2028
High	-
Avg	-
Low	-